Compare Johnson & Johnson (JNJ) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Suncor Energy Inc. — how do they compare? Johnson & Johnson trades at $261.2 (market cap $618.09B), while Suncor Energy Inc. trades at $72.18 (market cap $82.76B). The key difference: Johnson & Johnson is far larger — about 7.5× Suncor Energy Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Suncor Energy Inc. for 57 Days on average.
| JNJ | SU | |
|---|---|---|
Market Cap | $618.09B | $82.76B |
Volume | 6,050,983 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $278.43 | $71.87 |
52-Week Low | $186.00 | $38.17 |
Typical Hold Time | 129 Days | 57 Days |
Enterprise Value | $646.37B | $89.29B |
Dividend Yield | 2.09% | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
Suncor Energy (SU) trades at $72.17, up 5.91% in the past 24 hours and near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, though the RSI suggests mild overbought conditions. Fundamentally, the company maintains solid profitability with a 14.7% net income margin and a reasonable P/E of 13.46. Recent news highlights asset divestments and a CEO transition, while analyst consensus is strongly positive with 74% buy ratings.
The outlook for SU is favorable, supported by robust cash flow, aggressive shareholder returns, and a discounted valuation relative to peers. Key opportunities include global refining strength and debt reduction, while risks involve commodity price volatility and operational challenges. The stock's momentum and fundamental health suggest potential for continued upside, contingent on stable energy markets and execution of strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
